J.E. Tateson

1.3k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

J.E. Tateson is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, J.E. Tateson has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in J.E. Tateson's work include Inflammatory mediators and NSAID effects (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J.E. Tateson is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). J.E. Tateson collaborates with scholars based in United Kingdom. J.E. Tateson's co-authors include Salvador Moncada, John R. Vane, Roger Randall, L.G. Garland, John A. Salmon, Graham D. Spacey, Robert W. Bonser, H. F. Hodson, Charles H. Reynolds and P. Bhattacherjee and has published in prestigious journals such as The Lancet, Biochemical Journal and FEBS Letters.

In The Last Decade

J.E. Tateson

17 papers receiving 998 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1977 515 citations J.E. Tateson, Salvador Moncada et al. Prostaglandins profile →

Peers

Countries citing papers authored by J.E. Tateson

Since Specialization

Citations

This map shows the geographic impact of J.E. Tateson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.E. Tateson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.E. Tateson more than expected).

Fields of papers citing papers by J.E. Tateson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.E. Tateson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.E. Tateson. The network helps show where J.E. Tateson may publish in the future.

Co-authorship network of co-authors of J.E. Tateson

This figure shows the co-authorship network connecting the top 25 collaborators of J.E. Tateson. A scholar is included among the top collaborators of J.E. Tateson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.E. Tateson. J.E. Tateson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C 1994 ·Inflammation Research ·Roger Randall, K.E. Eakins, G.A. Higgs, John A. Salmon, J.E. Tateson	3
2	Antioxidants impair the coupling of cell-surface ligand receptors to the inositol lipid signalling pathway in human T lymphocytes but not in jurkat T lymphoblastic leukemia cells. Evidence that leukotrienes are not involved in the coupling mechanism 1993 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Masood Khan, Jamie Y. Jeremy, T. Hallinan, J.E. Tateson, A. Victor Hoffbrand, R. Gitendra Wickremasinghe	2
3	Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines 1993 ·Leukemia Research ·Masood Khan, J.E. Tateson, A. Victor Hoffbrand, R. Gitendra Wickremasinghe	16
4	Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil 1991 ·British Journal of Pharmacology ·Robert W. Bonser, N. Thompson, Roger Randall, J.E. Tateson, Graham D. Spacey, H. F. Hodson, L.G. Garland	106
5	A quantitative investigation into the dependence of Ca²⁺ mobilisation on changes in inositol 1,4,5‐trisphosphate levels in the stimulated neutrophil 1991 ·British Journal of Pharmacology ·Neil T. Thompson, Robert W. Bonser, J.E. Tateson, Graham D. Spacey, Roger Randall, H. F. Hodson, L.G. Garland	19
6	The temporal relationship between phospholipase activation, diradylglycerol formation and superoxide production in the human neutrophil 1990 ·Biochemical Journal ·N. Thompson, J.E. Tateson, Roger Randall, Graham D. Spacey, Robert W. Bonser, L.G. Garland	41
7	The Effects of a Novel Series of Selective Inhibitors of Arachidonate 5‐Lipoxygenase on Anaphylactic and Inflammatory Responses 1988 ·Annals of the New York Academy of Sciences ·P. Bhattacherjee, N. K. Boughton-Smith, R.L. Follenfant, L.G. Garland, G.A. Higgs, H. F. Hodson, (unknown), W. P. U. Jackson, Salvador Moncada, Adrian N. Payne, Roger Randall, Charles H. Reynolds, John A. Salmon, J.E. Tateson, Brendan J.R. Whittle	27
8	Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo 1988 ·British Journal of Pharmacology ·J.E. Tateson, Roger Randall, Charles H. Reynolds, W. P. U. Jackson, P. Bhattacherjee, John A. Salmon, L.G. Garland	150
9	A commentary on the inhibition by retinoids of leukotriene B₄ production in leukocytes 1987 ·FEBS Letters ·Roger Randall, J.E. Tateson, John A. Dawson, L.G. Garland	9
10	Activation and inhibition of 5-lipoxygenase in human polymorphs: comparison with protein kinase C 1986 ·Biochemical Society Transactions ·Roger Randall, J.E. Tateson, L.G. Garland	2
11	3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase 1984 ·Biochemical Pharmacology ·F. C. Copp, (unknown), J.E. Tateson	32
12	Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755C 1980 ·Inflammation Research ·Roger Randall, K.E. Eakins, G.A. Higgs, John A. Salmon, J.E. Tateson	93
13	The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings]. 1979 ·PubMed ·(unknown), Debra A. Goff, (unknown), A A Miller, J.E. Tateson, (unknown)	7
14	Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets breakdown → 1977 ·Prostaglandins ·J.E. Tateson, Salvador Moncada, John R. Vane	515
15	Inhibition of adenosine-3′, 5′-cyclic monophosphate phosphodiesterase by potential antiallergic compounds 1976 ·Life Sciences ·J.E. Tateson, David G. Trist	15
16	DOXANTRAZOLE, AN ANTIALLERGIC AGENT ORALLY EFFECTIVE IN MAN 1975 ·The Lancet ·(unknown), L.G. Garland, (unknown), D. T. D. Hughes, (unknown), (unknown), H. F. Hodson, J.E. Tateson	38
17	Early steps in the biosynthesis of mycobactins P and S 1970 ·Biochemical Journal ·J.E. Tateson	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact